Grants and Contributions:
Title:
Development of a microbiome diagnostic test for feline diabetes and other chronic conditions
Agreement Number:
948927
Agreement Value:
$182,000.00
Agreement Date:
May 1, 2020 - Mar 31, 2023
Description:
This project will involve the development and validation of an innovative molecular diagnostic for feline diabetes, as well as the expansion of this test to detect other small animal diseases beyond diabetes.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V6J 2H8
Reference Number:
172-2020-2021-Q1-948927
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
753696913
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 14 days. The total amended value is 31,000 dollars.
Amendment Date
Feb 2, 2023
Recipient's Legal Name:
Pawsperity Biotechnologies Inc.
Federal Riding Name:
Vancouver Granville
Federal Riding Number:
59036
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: